Outset Medical is a medical technology company, engaged in developing technology to reduce the cost and difficulty of dialysis. Co.'s Tablo® Hemodialysis System is designed for use from the hospital to the home. Tablo is a single enterprise solution for hemodialysis, comprised of a console with water purification, dialysate production and software and connectivity capabilities. Co. designed Tablo to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere, and by virtually anyone. Tablo can be used across multiple care settings and a range of clinical applications. The OM stock yearly return is shown above.
The yearly return on the OM stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2022 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the OM annual return calculation with any dividends reinvested as applicable (on ex-dates).
|